Get ahead of the CPT Evaluation and Management changes taking affect in 2021. Master the changes and learn how they will affect your practice.
5 Bootcamp sessions and 18 Symposium sessions
14 Presenters including CMS and AMA
On-demand session videos, purchase as bundles or individually
Billing Dermal Filler Injections
by Christine Woolstenhulme, QCC, QMCS, CPC, CMRS April 20th, 2017
When billing dermal filler injections, separate payment may be made under the OPPS and ASC payment systems for HCPCS G0429- Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy).
Use in addition:Q2026- Injection, radiesse, 0.1 ml, and Q2028 - Injection, sculptra, 0.5 mg
With a diagnosis ofB20 - Human immunodeficiency virus [HIV] disease or E88.1 - Lipodystrophy, not elsewhere classified.
Article Tags (click on a tag to see related articles)
Publish this Article on your Website, Blog or Newsletter
This article is available for publishing on websites, blogs, and newsletters. The article must be published in its entirety - all links must be active. If you would like to publish this article, please contact us and let us know where you will be publishing it. The easiest way to get the text of the article is to highlight and copy. Or use your browser's "View Source" option to capture the HTML formatted code.
If you would like a specific article written on a medical coding and billing topic, please Contact Us.
contact
innoviHealth Systems, Inc.
62 East 300 North
Spanish Fork, UT 84660
Phone: 801-770-4203 (9-5 Mountain)
Email:
Quick, Current, Complete - www.findacode.com